Recordati Pharma GmbH

Recordati Pharma GmbH is an international specialty pharmaceutical company committed to collaborating with other industry leaders to research and design innovative, high-standard treatments that enhance the quality of life and enable people to live longer, healthier, and happier lives.


About the Manufacturer

Founded in 2005, Recordati Pharma GmbH — formerly Merckle Recordati GmbH — distributes drugs and medical products on the German market. Recordati Pharma is the subsidiary of the Italian Recordati S.p.A. Group that is headquartered in Milan, Italy, and has global operations as well as strategic partnerships to improve access to its medications. Recordati has well-integrated operations, from R&D through chemical and finished product manufacture, as well as commercialization and licensing. The company continuously develops new medicines and believes research and development is a fundamental basis for its growth.

Manufacturer’s Brands

Recordati is focused mainly on the cardiovascular, urological, gastrointestinal and central nervous system areas. It also develops cosmetics, dietary supplements, pregnancy tests, over-the-counter (OTC) and non-prescription medications, anti-infectives, orthopaedic solutions, and other products. Among other medical medical devices, Recordati Pharma offers the Recosyn hyaluron products for the treatment of osteoarthritis. Recosyn solutions help to improve joint mobility and alleviate pain for approximately 6-12 months. You can buy Recosyn serial or single injections from Major Medical Solutions at the most reasonable price.

Manufacturer’s Strengths

Always focused on the development and offering of innovative drugs, Recordati is constantly committed to improving people’s health and quality of life, placing the patient at the center of its priorities. Recordati is committed towards innovation — and lays special emphasis on the marketing of high value-added products. The company is constantly expanding, with a mission to develop new technologies and treatments, and always looking to invest in medical breakthroughs that have the potential to provide a better future for people all around the world.